BR0313739A - Método para minimizar a possibilidade de resultados falso-positivos e falso-negativos na detecção de pequenas quantidades de lìquido amniótico em secreção vaginal e dispositivo para realizar o método - Google Patents

Método para minimizar a possibilidade de resultados falso-positivos e falso-negativos na detecção de pequenas quantidades de lìquido amniótico em secreção vaginal e dispositivo para realizar o método

Info

Publication number
BR0313739A
BR0313739A BR0313739-2A BRPI0313739A BR0313739A BR 0313739 A BR0313739 A BR 0313739A BR PI0313739 A BRPI0313739 A BR PI0313739A BR 0313739 A BR0313739 A BR 0313739A
Authority
BR
Brazil
Prior art keywords
detection
false
minimizing
possibility
small amounts
Prior art date
Application number
BR0313739-2A
Other languages
English (en)
Inventor
Dmitrii D Petrunin
Boris B Fuks
Evgeny I Zaraisky
Marina N Boltovskaya
Svetlana V Nazimova
Nelly A Starosvetskaya
Alexandr B Konstantinov
Margarita I Marshiskaia
Original Assignee
N Dia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31715979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0313739(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N Dia Inc filed Critical N Dia Inc
Publication of BR0313739A publication Critical patent/BR0313739A/pt
Publication of BRPI0313739B1 publication Critical patent/BRPI0313739B1/pt
Publication of BRPI0313739B8 publication Critical patent/BRPI0313739B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/471—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/805—Test papers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/97—Test strip or test slide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"MéTODO PARA MINIMIZAR A POSSIBILIDADE DE RESULTADOS FALSO-POSITIVOS E FALSO-NEGATIVOS NA DETECçãO DE PEQUENAS QUANTIDADES DE LìQUIDO AMNIóTICO EM SECREçãO VAGINAL E DISPOSITIVO PARA REALIZAR O MéTODO". A presente invenção refere-se a um método diagnóstico para a detecção de pequenas quantidades de líquido amniótico na vagina. Mais especificamente, a invenção refere-se à detecção de PAMG-1 na vagina utilizando anticorpos anti-PAMG-1.
BRPI0313739A 2002-08-13 2003-08-12 método para detectar infiltração de líquido amniótico em secreções vaginais e dispositivo para realizar um método de detecção BRPI0313739B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40340702P 2002-08-13 2002-08-13
PCT/US2003/025125 WO2004014220A2 (en) 2002-08-13 2003-08-12 Devices and methods for detecting amniotic fluid in vaginal secretions

Publications (3)

Publication Number Publication Date
BR0313739A true BR0313739A (pt) 2005-06-14
BRPI0313739B1 BRPI0313739B1 (pt) 2018-07-17
BRPI0313739B8 BRPI0313739B8 (pt) 2021-07-27

Family

ID=31715979

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0313739A BRPI0313739B8 (pt) 2002-08-13 2003-08-12 método para detectar infiltração de líquido amniótico em secreções vaginais e dispositivo para realizar um método de detecção

Country Status (18)

Country Link
US (7) US7709272B2 (pt)
EP (2) EP1535068B1 (pt)
JP (1) JP4625696B2 (pt)
KR (1) KR101056150B1 (pt)
CN (1) CN1697972B (pt)
AT (1) ATE465410T1 (pt)
AU (1) AU2003259751C1 (pt)
BR (1) BRPI0313739B8 (pt)
CA (1) CA2533915C (pt)
DE (1) DE60332248D1 (pt)
DK (2) DK1535068T3 (pt)
EA (1) EA008194B1 (pt)
ES (2) ES2344693T3 (pt)
MX (1) MXPA05001832A (pt)
PT (1) PT1535068E (pt)
SI (1) SI1535068T1 (pt)
WO (1) WO2004014220A2 (pt)
ZA (1) ZA200502078B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05001832A (es) 2002-08-13 2005-08-16 N Dia Inc Dispositivos y metodos para detectar fluido amniotico en secreciones vaginales.
CN1902496A (zh) * 2003-11-07 2007-01-24 赫普金尼克斯股份有限公司 结合测定组分
US20050233400A1 (en) * 2004-03-03 2005-10-20 Weiner Carl P Proteomic method for predicting success of rescue cerclage
WO2008001737A1 (fr) * 2006-06-26 2008-01-03 Nippon Telegraph And Telephone Corporation cellule d'écoulement et son processus de fabrication
KR100789849B1 (ko) * 2007-01-05 2007-12-28 재단법인서울대학교산학협력재단 자궁으로부터의 양수 포집을 위한 기구
JP5234453B2 (ja) * 2008-03-04 2013-07-10 国立大学法人富山大学 皮膚カテプシンの分析方法、皮膚の光ストレスの判定方法およびそのためのキット
CN101871943B (zh) * 2010-06-02 2015-01-07 成都创宜生物科技有限公司 以icam-1为检测指标的胎膜早破快速检测工具与检测盒
FR2960974B1 (fr) * 2010-06-03 2016-12-30 Biosynex Procede de detection de rupture de membranes
JP5903492B2 (ja) 2011-09-16 2016-04-13 クレド バイオメディカル ピーティーイー リミテッド 分子診断アッセイデバイス及び使用方法
CN102411052B (zh) * 2011-11-17 2014-01-29 成都创宜生物科技有限公司 以补体因子d为检测指标的子痫前期快速检测工具与试剂盒及制作方法
CN103175968A (zh) * 2011-12-20 2013-06-26 安徽深蓝医疗科技有限公司 一种胎膜早破检测试剂盒及制备方法
US9381351B2 (en) 2012-06-09 2016-07-05 Fempulse, Llc Devices and methods for stimulating nerves
US9248285B2 (en) 2012-06-09 2016-02-02 Fempulse, Llc Devices and methods for stimulating nerves
EP2863808B1 (en) 2012-06-22 2022-01-26 Preprogen LLC Method for obtaining fetal cells and fetal cellular components
EP2912458B1 (en) 2012-10-24 2018-07-18 NYU Winthrop Hospital Non-invasive biomarker to identify subjects at risk of preterm delivery
CN107727841B (zh) * 2013-01-02 2021-05-25 凯杰科学有限责任公司 预测孕妇分娩时间的方法
KR102220267B1 (ko) * 2013-07-11 2021-02-25 삼성전자주식회사 전자문서를 공유하는 방법 및 이를 위한 장치들
CA2962893C (en) * 2013-10-17 2023-06-06 Fempulse, Llc Devices and methods for stimulating nerves
CN105277656B (zh) 2014-07-01 2018-12-25 科蒙森斯公司 用于鉴定羊水的诊断组合物
US11079378B2 (en) * 2014-12-10 2021-08-03 Xpecting Diagnostics, Inc. Detection of analytes in bodily fluid to determine the initiation of parturition
CN105467131B (zh) * 2015-11-28 2017-11-28 美康生物科技股份有限公司 可以同时检测尿液和血清样本中α1‑微球蛋白的试剂盒
CN105699370B (zh) * 2016-01-20 2018-09-18 江西华清博恩生物科技有限公司 羊水检测指示剂组合物、其制备和相应的羊水检测护垫
US10935555B2 (en) 2016-12-22 2021-03-02 Qiagen Sciences, Llc Determining candidate for induction of labor
US10656164B2 (en) 2016-12-22 2020-05-19 Qiagen Sciences, Llc Screening asymptomatic pregnant woman for preterm birth
SG11202002065VA (en) 2017-09-13 2020-04-29 Progenity Inc Preeclampsia biomarkers and related systems and methods
KR102543041B1 (ko) * 2018-11-29 2023-06-14 엘지디스플레이 주식회사 외부 보상용 표시 장치 및 그 구동 방법
US20220296221A1 (en) * 2019-09-22 2022-09-22 Ecole Polytechnique Federale De Lausanne (Epfl) Device and Method for Pre-Term Birth Risk Assessment
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
NL7807532A (nl) 1978-07-13 1980-01-15 Akzo Nv Metaal-immunotest.
NL8000173A (nl) 1980-01-11 1981-08-03 Akzo Nv Toepassing van in water dispergeerbare, hydrofobe kleurstoffen als label in immunochemische testen.
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US5073484A (en) 1982-03-09 1991-12-17 Bio-Metric Systems, Inc. Quantitative analysis apparatus and method
US4594327A (en) 1983-11-02 1986-06-10 Syntex (U.S.A.) Inc. Assay method for whole blood samples
US4595661A (en) * 1983-11-18 1986-06-17 Beckman Instruments, Inc. Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect
US4703017C1 (en) 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
US4632901A (en) 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
JP2527933B2 (ja) 1984-06-13 1996-08-28 ユニリ−バ−・ナ−ムロ−ゼ・ベンノ−トシヤ−プ 特異的反応性サンプルの収集及び試験デバイス並びにその製造方法
US4806312A (en) 1985-08-28 1989-02-21 Miles Inc. Multizone analytical element having detectable signal concentrating zone
DE3544929C1 (de) 1985-12-19 1987-05-07 Messerschmitt Boelkow Blohm Gehaeuse zum Schutz von Sprengladungen
US4906439A (en) 1986-03-25 1990-03-06 Pb Diagnostic Systems, Inc. Biological diagnostic device and method of use
US4959305A (en) 1986-06-18 1990-09-25 Miles Inc. Reversible immobilization of assay reagents in a multizone test device
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5030558A (en) 1986-11-07 1991-07-09 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US5156952A (en) 1986-11-07 1992-10-20 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US4770853A (en) 1986-12-03 1988-09-13 New Horizons Diagnostics Corporation Device for self contained solid phase immunodiffusion assay
EP0280559B1 (en) 1987-02-27 1993-10-20 EASTMAN KODAK COMPANY (a New Jersey corporation) Agglutination immunoassay and kit for determination of a multivalent immune species using a buffered salt wash solution
JPH0664061B2 (ja) 1987-02-27 1994-08-22 イーストマン コダック カンパニー 免疫反応性試薬、その製造法及び免疫反応性種を測定するためのその用途
US4918025A (en) 1987-03-03 1990-04-17 Pb Diagnostic Systems, Inc. Self contained immunoassay element
US4857453A (en) 1987-04-07 1989-08-15 Syntex (U.S.A.) Inc. Immunoassay device
US5137808A (en) 1987-04-07 1992-08-11 Syntex (U.S.A.) Inc. Immunoassay device
DE560410T1 (de) 1987-04-27 2001-12-20 Unilever Nv Testgerät zur Durchführung von spezifischen Bindungsprüfungen.
DE3853515T3 (de) 1987-05-21 2005-08-25 Micromet Ag Multifunktionelle proteine mit vorbestimmter zielsetzung.
US5132405A (en) 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US4943522A (en) 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
US5120643A (en) 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
CA1337394C (en) 1987-11-17 1995-10-24 Nelson N. H. Teng Vaginal sample test and reagents
US5114673A (en) 1988-01-21 1992-05-19 Boehringer Mannheim Corporaton Apparatus for determination of a component in a sample
US4952517A (en) 1988-02-08 1990-08-28 Hygeia Sciences, Inc. Positive step immunoassay
NO164622C (no) * 1988-05-11 1990-10-24 Tore Lindmo Binaer immunometrisk partikkelbasert metode for maaling av spesifikke serum-antigener ved hjelp av vaeskestroemsmikrofotometri og et ferdigpreparert maaloppsett derav.
SG50681A1 (en) 1988-06-13 1998-07-20 American Biogenetic Sciences Method for the production of monoclonal antibodies utilizing a germfree animal
EP0347967A1 (en) 1988-06-23 1989-12-27 Agfa-Gevaert N.V. Photosensitive recording material suited for use in electrophotography
US5051237A (en) 1988-06-23 1991-09-24 P B Diagnostic Systems, Inc. Liquid transport system
US5037735A (en) 1988-06-24 1991-08-06 Microgenics Corporation Visual discrimination qualitative enzyme complementation assay
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US5232833A (en) * 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
US5252459A (en) 1988-09-23 1993-10-12 Abbott Laboratories Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles
IT1227293B (it) 1988-10-06 1991-04-05 Boehringer Biochemia Srl Dispositivo e metodo per la diagnosi di gravidanza
WO1990010061A1 (en) * 1989-03-02 1990-09-07 Griffith University Diamine oxidase and assay for rupture of amniotic membrane in pregnant mammals
CA2030517C (en) 1989-04-11 2001-05-29 Stephen W. Eason Multianalyte test vehicle
US5147609A (en) 1989-05-19 1992-09-15 Pb Diagnostic Systems, Inc. Assay element
US5252496A (en) 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
US5141871A (en) 1990-05-10 1992-08-25 Pb Diagnostic Systems, Inc. Fluid dispensing system with optical locator
FI84863C (fi) 1990-05-22 1992-01-27 Medix Biochemica Ab Oy Semikvantitativ eller kvalitativ immunometrisk testmetod och reagensfoerpackning.
FI86777C (fi) 1990-12-31 1992-10-12 Medix Biochemica Ab Oy Foerfarande foer diagnosticering av bristningen av fosterhinnorna samt reagensfoerpackning foer anvaendning daervid
US5138868A (en) 1991-02-13 1992-08-18 Pb Diagnostic Systems, Inc. Calibration method for automated assay instrument
FI94181C (fi) 1992-06-29 1995-07-25 Medix Biochemica Ab Oy Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
US5354692A (en) 1992-09-08 1994-10-11 Pacific Biotech, Inc. Analyte detection device including a hydrophobic barrier for improved fluid flow
US5308775A (en) 1992-09-15 1994-05-03 Abbott Laboratories Assay devices for concurrently detecting an analyte and confirming the test result
CN1088584A (zh) * 1992-12-22 1994-06-29 向明明 从体液中提取纤维结合蛋白的生产工艺
US5352582A (en) 1993-10-28 1994-10-04 Hewlett-Packard Company Holographic based bio-assay
US5597700A (en) 1994-04-28 1997-01-28 California Research, Llc Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
US5712172A (en) 1995-05-18 1998-01-27 Wyntek Diagnostics, Inc. One step immunochromatographic device and method of use
US5747273A (en) * 1996-05-07 1998-05-05 Diagnostic Systems Laboratories, Inc. Immunoassay of total insulin-like growth factor binding protein-1
RU2110800C1 (ru) * 1996-07-02 1998-05-10 Ангалева Елена Николаевна Способ ранней диагностики внутриутробного инфицирования
US6066464A (en) * 1996-12-10 2000-05-23 Diagnostic Systems Laboratories, Inc. Immunoassay of IGF family of peptides, their binding proteins and related molecules in dried whole blood filter paper spots
JP3644780B2 (ja) * 1996-12-25 2005-05-11 湧永製薬株式会社 免疫学的定量装置
US6248546B1 (en) * 1998-03-09 2001-06-19 Diagnostic Systems Laboratories, Inc. Assay of IGFBP complex
DE10121113A1 (de) 2001-04-28 2002-10-31 Gabriele Pecher Genmodifizierte YT Zelllinie und ihre Verwendung
MXPA05001832A (es) * 2002-08-13 2005-08-16 N Dia Inc Dispositivos y metodos para detectar fluido amniotico en secreciones vaginales.
ITMI20030643A1 (it) 2003-04-01 2004-10-02 Copan Innovation Ltd Tampone per il prelievo di campioni biologici
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
WO2009018607A1 (en) 2007-08-03 2009-02-12 Polartechnics Limited Device and method for biological sampling
EP3206009A1 (en) 2008-08-21 2017-08-16 DNA Genotek Inc. Sample receiving device
CN107727841B (zh) * 2013-01-02 2021-05-25 凯杰科学有限责任公司 预测孕妇分娩时间的方法
US10656164B2 (en) * 2016-12-22 2020-05-19 Qiagen Sciences, Llc Screening asymptomatic pregnant woman for preterm birth
US10935555B2 (en) * 2016-12-22 2021-03-02 Qiagen Sciences, Llc Determining candidate for induction of labor

Also Published As

Publication number Publication date
PT1535068E (pt) 2010-07-01
US7709272B2 (en) 2010-05-04
CA2533915C (en) 2020-09-22
US9429580B2 (en) 2016-08-30
EA008194B1 (ru) 2007-04-27
CN1697972B (zh) 2010-09-29
EP2204654A1 (en) 2010-07-07
AU2003259751C1 (en) 2009-09-17
BRPI0313739B8 (pt) 2021-07-27
EP1535068A4 (en) 2006-11-29
DE60332248D1 (de) 2010-06-02
JP4625696B2 (ja) 2011-02-02
ES2344693T3 (es) 2010-09-03
CN1697972A (zh) 2005-11-16
US20120009609A1 (en) 2012-01-12
KR20050062533A (ko) 2005-06-23
DK1535068T3 (da) 2010-08-09
AU2003259751A1 (en) 2004-02-25
US10422802B2 (en) 2019-09-24
MXPA05001832A (es) 2005-08-16
US20160327565A1 (en) 2016-11-10
EP2204654B1 (en) 2012-12-12
EP1535068B1 (en) 2010-04-21
US20100311190A1 (en) 2010-12-09
WO2004014220A2 (en) 2004-02-19
US8114610B2 (en) 2012-02-14
US9568479B2 (en) 2017-02-14
US20060240498A1 (en) 2006-10-26
DK2204654T3 (da) 2013-03-11
BRPI0313739B1 (pt) 2018-07-17
SI1535068T1 (sl) 2010-07-30
WO2004014220A3 (en) 2004-06-17
KR101056150B1 (ko) 2011-08-11
US20130071865A1 (en) 2013-03-21
US20170023582A1 (en) 2017-01-26
ATE465410T1 (de) 2010-05-15
EP1535068A2 (en) 2005-06-01
US20140011220A1 (en) 2014-01-09
JP2005535887A (ja) 2005-11-24
ZA200502078B (en) 2005-12-28
US9494596B2 (en) 2016-11-15
CA2533915A1 (en) 2004-02-19
AU2003259751B2 (en) 2009-03-19
ES2401036T3 (es) 2013-04-16
EA200500356A1 (ru) 2005-12-29

Similar Documents

Publication Publication Date Title
BR0313739A (pt) Método para minimizar a possibilidade de resultados falso-positivos e falso-negativos na detecção de pequenas quantidades de lìquido amniótico em secreção vaginal e dispositivo para realizar o método
Pepin et al. Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers
Kilmarx et al. HIV-1 seroconversion in a prospective study of female sex workers in northern Thailand: continued high incidence among brothel-based women
Schwebke et al. Molecular testing for Trichomonas vaginalis in women: results from a prospective US clinical trial
Risbud et al. The etiology of genital ulcer disease by multiplex polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted disease clinics in Pune, India
Mehta et al. Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection
ES2507092T3 (es) Sensor de pruebas de fluido que tiene respiraderos para dirigir el flujo de fluido
Huppert et al. Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians
Pope et al. Molecular subtyping of Treponema pallidum from North and South Carolina
BR0112667A (pt) processo de distinção entre estados biológicos baseados em padrões ocultos de dados biológicos
LAWSON et al. Objective markers of condom failure
Holanda Jr et al. Primary screening for cervical cancer through self sampling
BRPI0518405B8 (pt) conjunto de esferas para detectar uma cepa de hpv e/ou para diferenciar entre duas ou mais cepas de hpv, método para preparar o conjunto de esferas, método para diagnosticar infecção por hpv em um sujeito humano, uso do conjunto de esferas e método para detectar e/ou para diferenciar entre duas ou mais cepas de hpv particulares em uma amostra biológica
Zenilman et al. Polymerase chain reaction detection of Y chromosome sequences in vaginal fluid: preliminary studies of a potential biomarker for sexual behavior
Huppert et al. Abnormal vaginal pH and Mycoplasma genitalium infection
Rajaram et al. Laparoscopy in the diagnosis of tuberculosis in chronic pelvic pain
Ajenifuja et al. Comparison between self sampling and provider collected samples for Human Papillomavirus (HPV) Deoxyribonucleic acid (DNA) testing in a Nigerian facility
Wolff et al. Detection of Chlamydia trachomatis in semen by antibody-enzyme immunoassay compared with polymerase chain reaction, antigenenzyme immunoassay, and urethral cell culture
CN206057335U (zh) 层析法和酶化学法联合检测妇科阴道炎试剂盒
Gatechompol et al. Incidence, persistence, and factors associated with HPV infection among male adolescents with and without perinatally acquired HIV infection
CO5840255A1 (es) Un metodo mediante una prueba de aliento para la deteccion de microorganismos patogenos
Iloh et al. Sero-epidemiology of Hepatitis B surface antigenaemia among adult Nigerians with clinical features of liver diseases attending a primary-care clinic in a resource-constrained setting of eastern Nigeria
Gardella et al. Poor correlation between genital lesions and detection of herpes simplex virus in women in labor
Bollinger et al. Sensitivity of severe acute respiratory syndrome coronavirus type 2 rapid antigen point-of-care tests in vaccinated patients
Gaydos Rapid tests for sexually transmitted diseases

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B25G Requested change of headquarter approved
B25A Requested transfer of rights approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/08/2003, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO